Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Sunday, September 28

4:55 PM - 5:05 PM PT

141 - Preliminary Results of Hypofractionated Regional Nodal Radiation in Breast Cancer (HARVEST): A Randomized Non-Inferior Multi-Center Phase III Trial
Speaker: Xu, Fei-Fei, MD - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai
4:55 PM - 5:05 PM PT

147 - Bladder-Specific 15-Gene Transcriptomic Signature Predicts (Chemo)radiation Therapy Response in Muscle-Invasive Bladder Cancer
Speaker: Li, Xiaohui, MD - Department of Medical Oncology, Peking University First Hospital, Beijing
4:55 PM - 5:05 PM PT

153 - HPV ctDNA Kinetics during Radiation and in Surveillance in a Phase II De-Escalation Trial for Early-Stage p16+ Oropharynx Cancer
Speaker: Higgins, Luke, MD - University of Michigan, Ann Arbor, MI
4:55 PM - 5:05 PM PT

159 - Feasibility and Acceptability of Carotid Ultrasound to Identify Head and Neck Cancer Survivors with High Cardiovascular Risk after Radiation Therapy: Results of a Prospective Study
Speaker: Hughes, Ryan, MD - Wake Forest University School of Medicine, Winston Salem, NC
4:55 PM - 5:05 PM PT

166 - A Clinical Validation Study of Ionizing Radiation Acoustic Imaging (iRAI) for Real-Time Visualization of Radiation Therapy Dose in Liver Cancer Patients
Speaker: Zhang, Wei, PhD - University of Michigan, Ann Arbor, MI
4:55 PM - 5:05 PM PT

172 - The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma Microsatellitosis
Speaker: Nordlund, Kelsey - MD Anderson Cancer Center, Houston, TX
5:05 PM - 5:15 PM PT

142 - Moderate Hypofractionated Radiotherapy for Regional Nodal Irradiation and Postmastectomy Radiation Therapy: A Systematic Review and Meta-Analysis
Speaker: Boelke, Edwin, MD - University of Duesseldorf, Haan, Nordrhein-
5:05 PM - 5:15 PM PT

148 - Stereotactic intensity modulated radiotherapy after radical prostatectomy (SCIMITAR): Four-year outcomes of a phase II clinical trial
Speaker: Juarez Casillas, Jesus, MD, MS - UCLA, Los Angeles, CA
5:05 PM - 5:15 PM PT

154 - The Influence of Chemo-Radiotherapy Dose and Radiotherapy Volumes on Peripheral Immunity in HPV+ Oropharyngeal Cancer
Speaker: Riaz, Nadeem, MD, MS - memorial sloan kettering, new york, New York
5:05 PM - 5:15 PM PT

160 - Long-Term Decision Regret Among Patients with Localized Prostate Cancer: Results from a Population-Based Cohort
Speaker: Mali, Rahul, MD, MPH - University of Kansas Medical Center, Kansas City, KS
5:05 PM - 5:15 PM PT

167 - Impact of a Clinical Prototype Linac Dual-Layer Kv Detector on Contrast and Metal Artifact Reduction in Patient Conebeam CTs
Speaker: Harris, Thomas, PhD, DABR - Dana-Farber/Brigham and Womens Cancer Center, Boston, MA
5:05 PM - 5:15 PM PT

173 - A Prospective Single-Arm Trial of Postoperative 36 Gy in 10 Fractions for Merkel Cell Carcinoma
Speaker: Mitra, Devarati, MD, PhD - University of Texas MD Anderson Cancer Center, Houston, TX